Navigation Links
Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
Date:9/3/2007

Inclusion of Gerresheimer Stock in the SDAX as Per September 6, 2007

Outside the Normal Schedule Decision on Possible Inclusion in the MDAX to be Taken on 5 September

DÜSSELDORF, Germany, September 3 /PRNewswire/ -- Gerresheimer AG has been listed in the Prime Standard of the Frankfurter Stock exchange since June 11, 2007, following one of the largest IPOs of the year, with a total issue volume of more than 900 million euros. Gerresheimer stock will be included in the SDAX index of Deutsche Borse, Frankfurt am Main, on September 6, 2007 outside the normal schedule.

Possible inclusion of Gerresheimer stock in the MDAX index is independent of this decision. Changes in the composition of the selection indices are to be published by Deutsche Borse this coming Wednesday, 5 September.

Dr. Axel Herberg, CEO of Gerresheimer AG, in welcoming the decision, says: "We are pleased that our stock is to be included in the SDAX outside the normal schedule after only three months on the stock exchange and thereby becomes even more attractive."

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 37 production sites in Europe, North America and Asia and employs approximately 10,000 employees worldwide.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telefon +49-211-6181-250

Telefax +49-211-6181-241

e-mail b.lingenberg@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. The Dangers Of Vitamin A To Pregnant Women To Be Included On Label
2. Hepatitis B Vaccine To Be Included In National Immunization Programme
3. ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included
4. Meningitis Vaccine To Be Included In Childhood Immunization Programme
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. Eight More African Countries Included In US Malaria Program
7. Yoga, to Be Included in Schools as Part of the Curriculum
8. A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List
9. Gene linked to early puberty in girls
10. Cancer drugs in development nearly doubled since 1995
11. Nearly all asthma deaths preventable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Right now, behind ... The agency is hammering out a game plan to implement changes and compromises ... to affect FDA-regulated firms. The new law:, ,     Seeks ways ...
(Date:7/24/2017)... ... 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir of ... published author, Ed Clark. Ed Clark is a church music director and choral ... minister of music and worship leader for over fifty years. He has a ...
(Date:7/23/2017)... , ... July 23, 2017 , ... A 20-year-long ... St. Louis, and led by the Minneapolis Veterans Administration Health Care System overwhelmingly supports ... the disease offers very few benefits. , In the cases involved with this ...
(Date:7/23/2017)... ... July 23, 2017 , ... “I Am Not Nothin’: The Serpent ... who could barely read and write and a brokenhearted young soldier who turned to ... of age novel about the power of simple faith is the work of published ...
(Date:7/22/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 22, ... ... surgeries take place each year with the majority of patients not requiring pain ... American Orthopaedic Society for Sports Medicine’s Annual Meeting today in Toronto, Ontario, ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the publication ... research describes the use of its AVACEN Treatment Method ... from fibromyalgia. ... AVACEN Medical ... by chronic widespread pain. It affects approximately 200 to 400 million people ...
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , ... of new data that validate the use of MMprofiler ... patients with multiple myeloma (MM). In a poster presentation ... Hematology Association (EHA) in Madrid, Spain ... MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: